- Large clinico-molecular dataset supporting active programs today
- AI tools across oncology, cardiology, and more
- Established precision medicine presence across clinical programs
Best for
Oncology and precision medicine programs
Pricing
Custom
SoftFinders Score
8.3 / 10
Overview
What is Tempus?
Tempus is a precision medicine platform for oncology and broader care programs, combining clinical and molecular data with AI-assisted genomic interpretation.
- Clinical context: The platform supports precision-care decisions rather than replacing clinical interpretation, so every genomic result must be considered alongside the patient’s clinical picture.
- Best-fit environment: Oncology and precision medicine teams may benefit most where genomic testing, clinical data, and established specialist workflows can be coordinated effectively.
- Evaluation priorities: Buyers should confirm the available test menu, turnaround times, EHR result delivery, interpretation support, and fit across active oncology service lines.
- Commercial model: Pricing is sales-led and scoped per buyer, while meaningful value depends on sufficient clinico-molecular data depth and a defined precision-care use case.
A small pilot can clarify workflow fit, data requirements, and adoption needs before a wider rollout.
KEY FEATURES
What you get out of the box
Clinical Trials
Connects insights with clinical trial options
Precision Care
Supports precision-care decisions across patient populations
Data Platform
Unified clinico-molecular data platform
Reporting Tools
Reports genomic findings for clinical teams
Genomic Interpretation
Interprets genomic test results in context
Multiomics Analysis
Analyzes multiple omics data layers together
USE CASES
Where teams put it to work
Editorial Take
What we like, and what to verify
- Best value depends on mature precision-care use
- Enterprise deployment requires substantial data depth
- Broad product portfolio requires careful buyer navigation
Screenshots
A look inside

Alternatives
Tools to consider next
Why consider it
Multiomic AI for early cancer detection
Why consider it
Multi-cancer early detection from blood
Why consider it
Generative AI scribe for health systems
Why consider it
Microsoft and Nuance enterprise ambient scribe
Why consider it
Voice-driven AI scribe and EHR assistant
Why consider it
Ambient AI scribe for independent clinicians
FAQ
